Understanding the precise level at which ErbB2 up-regulates survivin expression will help to delineate the underlying signal transduction pathways and will allow better targeting of survivin in ErbB2-overexpressing breast cancer cells. This evidence concerns the gene BIRC5 and breast carcinoma.